-
Brian Atwood, Managing Director, Versant Ventures
-
Robert Beall, President & CEO, Cystic Fibrosis Foundation
-
Marc Beer, Chief Executive Officer, Aegerion Pharmaceuticals, Inc
-
Alexis Borisy, Chairman, Foundation Medicine
-
Ron Cohen, President & CEO, Acorda Therapeutics, Inc
-
John Crowley, Chairman & CEO, Amicus Therapeutics, Inc
-
Douglas Doerfler, President & CEO, MaxCyte, Inc
-
Glen Giovannetti, Global Biotechnology Leader, Ernst & Young, LLP
-
Maxine Gowen, President & CEO, Trevena, Inc
-
Faheem Hasnain, President & CEO, Receptos, Inc
-
Paul Hastings, President & CEO, OncoMed Pharmaceuticals, Inc
-
Jeffrey Hatfield, President & CEO, Vitae Pharmaceuticals, Inc
-
Russell Herndon, President & CEO, Hydra Biosciences, Inc
-
Daniel Junius, President & CEO, ImmunoGen, Inc
-
Perry Karsen, Chief Operations Officer, Celgene Corporation
-
Rachel King, President & CEO, GlycoMimetics, Inc
-
Robert Kiss, Managing Director/Portfolio Manager, JP Morgan Asset Management
-
Scott Koenig, President & CEO, MacroGenics, Inc
-
Barbara Kosacz, Partner, Cooley, LLP
-
Emer Leahy, President & CEO, PsychoGenics, Inc
-
Jonathan Leff, Partner, Deerfield
-
Nick Leschly, chief bluebird, bluebird bio
-
John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals, Inc
-
Edward Mathers, Partner, New Enterprise Associates
-
Thomas Mathers, Chief Executive Officer, CoLucid Pharmaceuticals, Inc
-
Gordon McCauley, President & CEO, Allon Therapeutics, Inc
-
Russell Medford, President & CEO, Salutria Pharmaceuticals, LLC
-
John Mendlein, Chairman & CEO, aTyr Pharma
-
Steven Mento, Co-Founder, President, Chairman & CEO, Conatus Pharmaceuticals, Inc
-
Kenneth Moch, President & CEO, Chimerix, Inc
-
Arlene Morris, Chief Executive Officer, Syndax Pharmaceuticals, Inc
-
Mike Naraci, Chief Executive Officer, OrexigenTherapeutics, Inc
-
John Orwin, Chief Executive Officer, Affymax, Inc
-
Jeffrey Ostrove, President & CEO, Ceregene, Inc
-
Stuart Peltz, President & CEO, PTC Therapeutics, Inc
-
Adelene Perkins, President & CEO, Infinity Pharmaceuticals, Inc
-
Kristine Peterson, Chief Executive Officer, Valeritas, Inc
-
Mark Pruzanski, Founder, President & CEO, Intercept Pharmaceuticals, Inc
-
Timothy Rodell, President & CEO, GlobeImmune, Inc
-
Arthur Sands, President & CEO, Lexicon Pharmaceuticals, Inc
-
David Schenkein, Chief Executive Officer, Agios Pharmaceuticals, Inc
-
Moncef Slaoui, Chairman, Research & Development, GlaxoSmithKline, plc
-
Gil Van Bokkelen, Chairman & CEO, Athersys, Inc
-
Harold Van Wart, President, Director & CEO, Metabolex, Inc
-
Timothy Walbert, President, Chairman & CEO, Horizon Pharma, Inc
-
Kleanthis Xanthopoulos, President & CEO, Regulus Therapeutics, Inc
-
Bradford Zakes, Chief Executive Officer, Cerevast Therapeutics, Inc
-
Stephen Sherwin, Chair Emeritus(Non-Voting Member)